8-Bromo-2-chloro-7-methylquinazoline

Catalog No.: 
ACSHWX014
CAS No.: 
1388049-83-9
Molecular Formula: 
C9H6BrClN2
Molecular Weight: 
257.52
8-Bromo-2-chloro-7-methylquinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$121.00In stockInquiry
100mg95%$213.00In stockInquiry
250mg95%$344.00In stockInquiry
1g95%$928.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Bromo-2-chloro-7-methylquinazoline
IUPAC Name8-bromo-2-chloro-7-methylquinazoline
MDL No.MFCD22561825
Molecular FormulaC9H6BrClN2
Molecular Weight257.52
SMILESCC1=C(Br)C2=NC(Cl)=NC=C2C=C1
InChI KeyFVEJXCYVFHKJAT-UHFFFAOYSA-N
Synonym8-Bromo-2-chloro-7-methyl-quinazoline;Quinazoline, 8-bromo-2-chloro-7-methyl-
CAS No.1388049-83-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSHWX014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHWX014 route product structure diagram
    ACSHWX0141388049-83-9In Stock
Inquiry

2. ACSHWX014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACSHWX014 route product structure diagram
    ACSHWX0141388049-83-9In Stock
Inquiry

3. ACSHWX014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSHWX014 route product structure diagram
    ACSHWX0141388049-83-9In Stock
Inquiry

Comments (0)